| 缩写名/全名 |
FUTURE MED CHEM
Future Medicinal Chemistry |
||||||||||||||||||||||||
| ISSN号 | 1756-8919 | ||||||||||||||||||||||||
| 研究方向 | CHEMISTRY, MEDICINAL- | ||||||||||||||||||||||||
| 影响因子 | 2015:3.345, 2016:3.556, 2017:3.969, 2018:3.617, 2019:3.607, | ||||||||||||||||||||||||
| 出版国家 | ENGLAND | ||||||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||||||
| 年文章数 | 179 | ||||||||||||||||||||||||
| 出版年份 | 2009 | ||||||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||||||
| 审稿周期(仅供参考) | 偏慢,4-8周 |
||||||||||||||||||||||||
| 录用比例 | |||||||||||||||||||||||||
| 投稿链接 | http://www.future-science.com/page/SubmitArticle | ||||||||||||||||||||||||
| 投稿官网 | http://www.future-science.com/loi/fmc | ||||||||||||||||||||||||
| h-index | 54 | ||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-8919%5BISSN%5D | ||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | The synthesis and biological evaluation of a new bioactive metabolite of mosapride as a potential gastroprokinetic agent. Author: Yao J1, Li K1, Song Y2, He Z1, Liu Z3, Zhao L1, Wang S2. Journal: Future Med Chem. 2019 Jan;11(1):21-32. doi: 10.4155/fmc-2018-0243. Epub 2018 Dec 11. PubMed DOI |
| 2. | Alizarin increase glucose uptake through PI3K/Akt signaling and improve alloxan-induced diabetic mice. Author: Xu L1,2, Xing M1,2, Xu X2, Saadeldeen FS2, Liu Z1,2, Wei J1,2, Kang W1,2. Journal: Future Med Chem. 2019 Mar;11(5):395-406. doi: 10.4155/fmc-2018-0515. Epub 2019 Jan 16. PubMed DOI |
| 3. | Deep learning for molecular generation. Author: Xu Y1, Lin K2, Wang S3, Wang L1, Cai C1, Song C1, Lai L1,2, Pei J1. Journal: Future Med Chem. 2019 Mar;11(6):567-597. doi: 10.4155/fmc-2018-0358. Epub 2019 Jan 30. PubMed DOI |
| 4. | Proteolysis-targeting chimeras for targeting protein for degradation. Author: Qi J1, Zhang G2. Journal: Future Med Chem. 2019 Apr;11(7):723-741. doi: 10.4155/fmc-2018-0557. Epub 2019 Feb 1. PubMed DOI |
| 5. | Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy. Author: Ju H1, Zhan P1, Liu X1. Journal: Future Med Chem. 2019 Feb 14. doi: 10.4155/fmc-2018-0489. [Epub ahead of print] PubMed DOI |
| 6. | Improving the accuracy of predicting protein-ligand binding-free energy with semiempirical quantum chemistry charge. Author: Peng C1,2, Wang J1, Yu Y1,2, Wang G1,2, Chen Z1,2, Xu Z1, Cai T1, Shao Q1, Shi J3, Zhu W1,2,4. Journal: Future Med Chem. 2019 Feb 25. doi: 10.4155/fmc-2018-0207. [Epub ahead of print] PubMed DOI |
| 7. | Gaseous signaling molecules and their application in resistant cancer treatment: from invisible to visible. Author: Cui Q1,2, Yang Y2, Ji N2,3, Wang JQ2, Ren L1, Yang DH2, Chen ZS2. Journal: Future Med Chem. 2019 Feb 25. doi: 10.4155/fmc-2018-0403. [Epub ahead of print] PubMed DOI |
| 8. | Discovery of novel anti-influenza agents via contemporary medicinal chemistry strategies (2014-2018 update). Author: Jia R1, Zhang J1, Ju H1, Kang D1, Fang Z2, Liu X1, Zhan P1. Journal: Future Med Chem. 2019 Mar;11(5):375-378. doi: 10.4155/fmc-2018-0397. Epub 2019 Mar 19. PubMed DOI |
| 9. | Characteristics of parathyroid hormone-1 receptor agonists and antagonists. Author: Zhong Y1, Li X1, Zhu D1, Zhao N1, Yao H1, Lin K1. Journal: Future Med Chem. 2019 Apr 18. doi: 10.4155/fmc-2018-0508. [Epub ahead of print] PubMed DOI |
| 10. | Bioactive isoquinolinequinone alkaloids from the South China Sea nudibranch Jorunna funebris and its sponge-prey Xestospongia sp. Author: Huang RY, Chen WT, Kurtán T, Mándi A, Ding J, Li J, Li XW, Guo YW. Journal: Future Med Chem. 2016 Jan;8(1):17-27. doi: 10.4155/fmc.15.169. Epub 2015 Dec 21. PubMed |
|
|
